Your browser doesn't support javascript.
loading
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
Gibson, C Michael; Kerneis, Mathieu; Yee, Megan K; Daaboul, Yazan; Korjian, Serge; Mehr, Ali Poyan; Tricoci, Pierluigi; Alexander, John H; Kastelein, John J P; Mehran, Roxana; Bode, Christoph; Lewis, Basil S; Mehta, Ravindra; Duffy, Danielle; Feaster, John; Halabi, Majdi; Angiolillo, Dominick J; Duerschmied, Daniel; Ophuis, Ton Oude; Merkely, Bela.
Afiliação
  • Gibson CM; From the PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, MA. Electronic address: mgibson@bidmc.harvard.edu.
  • Kerneis M; From the PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, MA.
  • Yee MK; From the PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, MA.
  • Daaboul Y; From the PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, MA.
  • Korjian S; From the PERFUSE Study Group, Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, MA.
  • Mehr AP; Nephrology Division, Department of Medicine, Beth Israel Deaconess Medical, Harvard Medical School, Boston, MA.
  • Tricoci P; Duke Clinical Research Institute, Cardiovascular Division, Department of Medicine, Duke Health, Durham, NC.
  • Alexander JH; Duke Clinical Research Institute, Cardiovascular Division, Department of Medicine, Duke Health, Durham, NC.
  • Kastelein JJP; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Mehran R; Cardiovascular Institute, Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Bode C; Department of Cardiology and Angiology I, Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lewis BS; Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Mehta R; Division of Nephrology-Hypertension, University of California San Diego School of Medicine, San Diego, CA.
  • Duffy D; CSL Behring, King of Prussia, PA.
  • Feaster J; CSL Behring, King of Prussia, PA.
  • Halabi M; Department of Cardiology, Ziv Medical Center, Derech HaRambam, Tsfat 13100, Israel.
  • Angiolillo DJ; Division of Cardiology, Department of Medicine, University of Florida, Gainesville, FL.
  • Duerschmied D; Department of Cardiology and Angiology I, Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Ophuis TO; Department of Cardiology, Canisius Wilhelmina Ziekenhuis, Nijmegen, the Netherlands.
  • Merkely B; Heart and Vascular Center, Semmelweis University, H-1122 Városmajor str 68, Budapest, Hungary.
Am Heart J ; 208: 81-90, 2019 02.
Article em En | MEDLINE | ID: mdl-30580130
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Injúria Renal Aguda / Lipoproteínas HDL / Infarto do Miocárdio Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Am Heart J Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Injúria Renal Aguda / Lipoproteínas HDL / Infarto do Miocárdio Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male Idioma: En Revista: Am Heart J Ano de publicação: 2019 Tipo de documento: Article